4,6-Dibenzamidopyrazolo[3,4-d]pyrimidine is a highly selective inhibitor of cytomegalovirus adsorption to cells
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 13 (1) , 1-10
- https://doi.org/10.1016/0166-3542(90)90040-e
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1988
- Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine on herpes virusesJournal of Medicinal Chemistry, 1988
- Use of Ganciclovir to Treat Serious Cytomegalovirus Infections in Patients with AIDSThe Journal of Infectious Diseases, 1987
- In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegalovirusesAntiviral Research, 1986
- Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegalovirusesAntimicrobial Agents and Chemotherapy, 1985
- Death in the AIDS Patient: Role of CytomegalovirusNew England Journal of Medicine, 1983
- Evaluation of the anti-herpesvirus drug combinations: Virazole plus arabinofuranosylhypoxanthine and Virazole plus arabinofuranosyladenineAntiviral Research, 1982
- Antiviral Activity of Extracts from Marine AlgaeAntimicrobial Agents and Chemotherapy, 1978
- PERFLUOROTHIOCARBONYL COMPOUNDSJournal of the American Chemical Society, 1961